RecruitingNot ApplicableNCT06247397

Effect of HIgh-flow Therapy in Long-term Oxygen Therapy

Effect of HIgh-flow Therapy in Long-term Oxygen Therapy (HILOT): A Multicenter, Registry-based, Randomized Clinical Trial


Sponsor

Skane University Hospital

Enrollment

310 participants

Start Date

Jun 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a registry-based, randomized, controlled clinical trial of the effect of added high-flow oxygen therapy (using the device Lumis HFT) during one year in people with long-term oxygen therapy (LTOT) for chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether high-flow oxygen therapy (HFOT) — which delivers warm, humidified oxygen at a higher flow rate than standard oxygen — works better than standard long-term oxygen therapy (LTOT) at home for people with chronic lung diseases (COPD or pulmonary fibrosis/ILD) who already need daily supplemental oxygen. **You may be eligible if...** - You are 40 years or older - You have been prescribed long-term home oxygen therapy for at least 15 hours per day for at least 28 days - Your main underlying condition is COPD or interstitial lung disease (ILD) - You use an oxygen concentrator as your stationary home oxygen source (including at night) - Your BMI is below 35 **You may NOT be eligible if...** - You have previously used or are currently using home high-flow oxygen therapy - You use a home ventilator or CPAP machine - You have been hospitalized in the past 2 weeks - You are a current smoker or have open flames near your oxygen source - Your blood CO2 level is very high, suggesting you are retaining too much carbon dioxide - You have suspected severe sleep apnea or obesity-related breathing problems Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAdded high-flow oxygen therapy

Added high-flow oxygen therapy using the device Lumis HFT during nighttime and at the patient's discretion daytime, with the usual care (low-flow oxygen therapy) the rest of the time.

OTHERStandard care

Standard care with low-flow oxygen therapy in accordance with clinical routine.


Locations(2)

Research Unit, Blekinge University of Technology

Karlskrona, Blekinge County, Sweden

Department of Heart, Lung and Clinical Physiology, Örebro University Hospital

Örebro, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06247397


Related Trials